omniture
盟科药业

Latest News

MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference

* MicuRx showcased the latest research progress on their pipeline products, MRX-5 and MRX-8, at t...

2024-07-18 13:19 1170

MicuRx: Successful Completion of Phase I Clinical Trial for Self-Developed MRX-8 Antibacterial Drug in China

* According to the World Health Organization (WHO), millions of patients face treatment difficult...

2024-06-06 19:52 1768

First Subject Enrolled in Phase 1 Study of MRX-5

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. (herein...

2023-11-20 18:34 1391

MicuRx announces poster presentation and participation in ID Week 2023 Conference

FOSTER CITY, Calif., Oct. 11, 2023 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a biopharmaceutica...

2023-10-11 23:33 1657

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

FOSTER CITY, Calif., Sept. 22, 2023 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a biopharmaceutic...

2023-09-22 16:41 1375

Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc.

SHANGHAI, Feb. 8, 2023 /PRNewswire/ -- Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx," 688373) ...

2023-02-08 16:05 2259

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection

SHANGHAI, June 3, 2021 /PRNewswire/ -- MicuRx Pharmaceutical Co., Ltd. (MicuRx), a leading biopharm...

2021-06-03 22:15 1571